| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COVID-19 research v0.160 | UNC93B1 | Abdelazeem Elhabyan reviewed gene: UNC93B1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: Other | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.36 | UNC93B1 |
Ellen McDonagh Mode of inheritance for gene UNC93B1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal Added phenotypes Herpetic encephalitis (HSE); Herpes simplex virus 1 encephalitis; Herpes simplex encephalitis, susceptibility to, 1; {Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1} 610551; Defects in Intrinsic and Innate Immunity for gene: UNC93B1 Publications for gene UNC93B1 were updated from 26621750 to 16973841; 16415873; 29768176; 26621750 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.36 | C9 |
Ellen McDonagh gene: C9 was added gene: C9 was added to Viral susceptibility. Sources: Expert Review Green,ESID Registry 20171117,North West GLH,Victorian Clinical Genetics Services,GRID V2.0,NHS GMS,London North GLH,IUIS Classification February 2018 Mode of inheritance for gene: C9 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: C9 were set to 9634479; 9570574; 9144525; 10072634 Phenotypes for gene: C9 were set to Mild susceptibility to disseminated neisserial infections; Complement component 9 deficiency; Complement Deficiencies; Susceptibility to invasive bacterial infection, especially meningococcal; C9 deficiency, 613825 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research v0.27 | UNC93B1 |
Ellen McDonagh Source Melbourne Genomics Health Alliance Immunology Flagship was added to UNC93B1. Source Victorian Clinical Genetics Services was added to UNC93B1. Source Expert Review Green was added to UNC93B1. Rating Changed from Red List (low evidence) to Green List (high evidence) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research | UNC93B1 | Ellen McDonagh added UNC93B1 to panel | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COVID-19 research | UNC93B1 | Ellen McDonagh reviewed UNC93B1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||